-
EP3844297
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3844297
| EP3844297 - PEPTIDES HAVING IMMUNOMODULATORY PROPERTIES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 04.06.2021 Database last updated on 22.08.2024 | |
| Former | The international publication has been made Status updated on 07.03.2020 | Most recent event Tooltip | 13.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Riptide Bioscience, Inc. 941 Railroad Avenue Vallejo, California 94592 / US | [2021/27] | Inventor(s) | 01 /
JAYNES, Jesse 941 Railroad Avenue Vallejo, California 94592 / US | 02 /
LOPEZ, Henry Wilfred 941 Railroad Avenue Vallejo, California 94592 / US | 03 /
MARTIN, George R. 941 Railroad Avenue Vallejo, California 94592 / US | 04 /
YATES, Clayton 941 Railroad Avenue Vallejo, California 94592 / US | 05 /
GARVIN, Charles 941 Railroad Avenue Vallejo, California 94592 / US | [2021/27] | Representative(s) | Arnold & Siedsma Bezuidenhoutseweg 57 2594 AC The Hague / NL | [2021/27] | Application number, filing date | 18931536.9 | 29.08.2018 | [2021/27] | WO2018US48632 | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2020046297 | Date: | 05.03.2020 | Language: | EN | [2020/10] | Type: | A2 Application without search report | No.: | EP3844297 | Date: | 07.07.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.03.2020 takes the place of the publication of the European patent application. | [2021/27] | Search report(s) | International search report - published on: | US | 05.03.2020 | (Supplementary) European search report - dispatched on: | EP | 03.08.2022 | Classification | IPC: | C12Q1/68 | [2021/27] | CPC: |
C07K7/06 (EP,KR);
A61K31/337 (EP);
A61K31/7068 (EP);
A61K38/08 (KR);
A61K38/14 (EP);
A61K39/39 (EP);
A61K45/06 (EP);
A61P29/00 (EP,KR);
A61P37/02 (KR);
| C-Set: |
A61K31/337, A61K2300/00 (EP);
A61K31/7068, A61K2300/00 (EP);
A61K38/14, A61K2300/00 (EP);
A61K39/39, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/27] | Title | German: | PEPTIDE MIT IMMUNOMODULATORISCHEN EIGENSCHAFTEN | [2021/27] | English: | PEPTIDES HAVING IMMUNOMODULATORY PROPERTIES | [2021/27] | French: | PEPTIDES AYANT DES PROPRIÉTÉS IMMUNO-MODULATRICES | [2021/27] | Entry into regional phase | 23.03.2021 | National basic fee paid | 23.03.2021 | Search fee paid | 23.03.2021 | Designation fee(s) paid | 23.03.2021 | Examination fee paid | Examination procedure | 23.03.2021 | Examination requested [2021/27] | 27.02.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 23.03.2021 | Renewal fee patent year 03 | 12.10.2021 | Renewal fee patent year 04 | 11.08.2022 | Renewal fee patent year 05 | 24.08.2023 | Renewal fee patent year 06 | 13.08.2024 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.08.2021 | 04 M06 Fee paid on 12.10.2021 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ID]US2012270770 (JAYNES JESSE MICHAEL [US]) [ID] 1-3,5,8-15* Abstract; claim 2; paragraph 15 *; | [ID]WO2016061133 (RIPTIDE BIOSCIENCE INC [US]) [ID] 1-3,5,8-15 * Abstract; paragraph 8; tables 3-9; claims, in particular claims 1 and 25; examples, in particular examples 6, 10-13. * |